Alphamab Oncology

HKEX:9966.HK

2.53 (HKD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22019 Q12018 Q42018 Q22018 Q12017 Q42017 Q22017 Q12016 Q4
Operating Activities:
Net Income -170.731-39.862-178.413-147.309-145.053-267.364-324.666-103.1-773.955-58.785-208.185-97.892-51.951-37.461-37.461-8.265-8.265-8.265
Depreciation & Amortization 36.76532.35331.91423.27421.72419.37816.01214.1156.7445.0292.9434.4882.0741.6411.6410.1290.1290.129
Deferred Income Tax 02.316-18.40819.72810.4092.616-2.605-11.719-64.20425.210-9.5717.17400000
Stock Based Compensation 9.2464.0468.0745.2184.1034.06512.64120.08678.66712.35622.75622.7560.26300000
Change In Working Capital -3.40913.2044.5541.971-21.203-1.242-30.111-5.072-14.053-42.278-3.051-8.095-7.437-0.831-0.831-0.163-0.163-0.163
Accounts Receivables 16.424-8.065-0.65-7.234-7.60601.293-1.293-9.051-24.1280-14.639-2.40100000
Change In Inventory -15.8141.70310.984-17.712-6.906-6.681-11.329-7.074-5.412-13.438-4.7131.454-5.036-0.896-0.896-0.78-0.78-0.78
Change In Accounts Payables 000000000-1.6620-1.662-0.06400000
Other Working Capital -4.01919.566-5.7826.917-6.6915.439-20.0753.2950.41-4.7121.6625.0900.0640.0640.6170.6170.617
Other Non Cash Items -1.074-83.377-20.403-29.18835.86529.127126.805-73.89587.114-26.336129.16334.10830.56813.18313.183-7.991-7.991-7.991
Operating Cash Flow -129.203-73.636-154.274-146.034-104.564-216.036-199.319-147.861-115.483-110.014-56.374-67.391-26.483-23.469-23.469-16.29-16.29-16.29
Investing Activities:
Investments In Property Plant And Equipment -14.065-22.119-64.76-64.891-100.655-57.464-45.779-45.043-97.739-73.634-42.843-46.536-26.582-18.28-18.28-2.088-2.088-2.088
Acquisitions Net 000000000125.5020125.502-0.1500000
Purchases Of Investments 000000000-287.277-287.277-287.277-12.225-12.225-12.225-8.5-8.5-8.5
Sales Maturities Of Investments 000000000161.776161.776161.77612.37512.37512.37511.11311.11311.113
Other Investing Activites 152.433-134.356478.127502.2814.92717.463219.568-1,652.429160.362-643.002168.3455.201-4.19318.1318.13-0.525-0.525-0.525
Investing Cash Flow 138.368-156.475413.367437.389-85.735659.999173.789-1,697.47262.623-716.636-168.345-41.335-30.775-18.13-18.130.5250.5250.525
Financing Activities:
Debt Repayment 0-61.7190-111.7580-81.0120-4.3750-40.52900-52.987-16.882-16.882000
Common Stock Issued 000000000411.547411.547411.5470.0020.0020.002000
Common Stock Repurchased 000000000000000000
Dividends Paid 000000000000000000
Other Financing Activities -39.557319.348-186.156-12.988288.451-5.561-31.003221.9571,667.683405.369-411.547727.98617.82716.8816.88000
Financing Cash Flow -39.557257.629-186.156-124.746288.45175.451-31.003217.5821,667.683445.898411.547727.98670.814-58.581-58.5810.50.50.5
Other Information:
Effect Of Forex Changes On Cash -19.92239.59518.8857.4523.136-2.7171.6610.078-0.6180.3020.027-8.6982.1842.1842.18415.26815.26815.268
Net Change In Cash 067.11391.822174.061101.288516.697-54.872-1,627.6731,614.20595.134308.539443.81723.136158.414158.4140.0030.0030.003
Cash At End Of Period 1,136.3021,136.3021,069.189977.367803.306702.018185.321240.1931,867.767253.562466.967466.96723.15158.428158.4280.0140.0140.014